Amplidiag® CarbaR+MCR

CE-IVD. For in vitro diagnostic use.

 

Amplidiag® CarbaR+MCR identifies clinically most relevant carbapenemase groups as well as colistin resistance markers in one single test.

 

This molecular diagnostic test has been designed to be a cost-effective solution for high-volume screening directly from stool, rectal swabs and pure culture samples for the diagnosis of carbapenemase-producing organisms (CPO) and colistin-resistant Enterococci (CRE).

 

This qualitative multiplex real-time PCR test gives results within a few hours, as opposed to days with culture-based screening methods. By allowing rapid and reliable detection of antibiotic resistances, Amplidiag CarbaR+MCR supports decisions to manage efficiently epidemiological and infection control measures and improve patient care.

 

 



  • KPC
  • NDM
  • VIM
  • IMP
  • OXA-48, OXA-181
  • Acinetobacter OXA* (ISAbaI-OXA-51, OXA-23, OXA-24/40, OXA58
  • MCR (MCR-1, MCR-2)
  • GES (GES-2, GES-4 through GES-6, GES-13 through GES-16, GES-18, GES-20, GES-21, GES-24)

*See user manual for detailed variant information

  • Sample material: DNA extracted from stool samples, rectal swabs or pure culture
  • Format: Multiplex real-time PCR
  • Result analysis and reporting: Automated with Amplidiag Analyzer software

• Flexible sample formats
• All targets detected and reported in one single test, from one single sample
• Results in <2h
• Suited for medium- and high-volume screening
• Automated results analysis with Amplidiag Analyzer software
• Workflow automation with Amplidiag Easy

Amplidiag Easy
• Bio-Rad CFX PCR instrument
• And more! Contact us at sales@mobidiag.com for more information on compatibility

If you are interested in the effective screening of key antimicrobial resistances, contact sales@mobidiag.com for more information and test use possibilities. We’re here to help!